# The Effect of Probiotics on Depression Syndrome and Risk Factors of Cardiovascular Disease in Hemodialysis Patients

> **NCT05724511** · PHASE4 · COMPLETED · sponsor: **China Medical University Hospital** · enrollment: 55 (actual)

## Conditions studied

- Depression Mild
- Cardiovascular Diseases

## Interventions

- **DRUG:** MIYAIRI 588

## Key facts

- **NCT ID:** NCT05724511
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-27
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-31
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05724511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05724511, "The Effect of Probiotics on Depression Syndrome and Risk Factors of Cardiovascular Disease in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05724511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*